David S. Snyder brings to Invenra more than 25 years’ experience as the CFO of public and high growth companies. Mr. Snyder currently serves as the CFO of DisperSol Technologies, LLC and its wholly owned subsidiary Austhera BioSciences, Inc. DisperSol and Austhera are currently advancing four late-stage, small molecule drugs through the clinic and are using their proprietary KinetiSol platform to build a pipeline of NCEs. Prior to joining DisperSol/Austhera, Mr. Snyder was the CFO of Exicure Inc. (Nasdaq: XCUR) a company developing nucleic acid therapeutics and prior to that, was the CFO of Cellular Dynamics, Inc. (Nasdaq: ICEL) a company developing iPSC-based stem cell tools and primary cell therapeutics. Mr. Snyder also previously served as Senior Vice President of Finance, Site Vice President and Chief Financial Officer of Roche NimbleGen. Prior, Mr. Snyder was CFO of companies in real estate, software, and manufacturing. He received his BA summa cum laude from Ottawa University and his MBA with high honors from the Harvard Business School, where he was designated a George Fisher Baker Scholar.